Microbot Medical price to sales ratio MBOT

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 97.3×; Mar 2017
Peer median: 1.6×

Microbot Medical's price to sales ratio is not a meaningful number today: revenue for one or more of the four quarters through 2026-06-30 is missing, so twelve months can't be added up.

It was last meaningful in Mar 2017, at 97.3×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2017	97.3×	71.8×	128×
2016	96.5×	35.3×	186×
2015	36.6×	36.3×	73.2×
2014	55.2×	54.4×	103×
2013	63.9×	37.1×	74.7×
2012	33.5×	10.5×	41.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest Microbot Medical's size, closest first, today.

Company	Price to sales ratio
MBOTMicrobot Medical	n/m
APTAlpha Pro Tech	0.9×
KEQUKewaunee Scientific	0.3×
NEPHNephros	1.9×
PDEXPro DEX	2.6×
UTMDUtah Medical Products	6.5×
INFUInfuSystem	1.9×
EMBCEmbecta	0.4×
TCMDTactile Systems Technology	1.5×
MDXGMimedx	1.6×
Peer median	1.6×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Microbot Medical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.